4169.TW · TCM
Taiwan · RS rating 14 · As of 2026-10-08
| Price | 147.50 TWD |
|---|---|
| 1-day change | -2.6% |
| RS rating (overall / 1M / 3M / 12M) | 14 / 32 / 1 / 71 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 35 / 16 / 37 |
| Industry group (rank) | Biotechnology & Medical Care (50) |
| EPS growth Q/Q | +71.1% |
| Sales growth Q/Q | +4.7% |
| Distance from 52-week high | +47.4% |
| Market cap (USD) | $313.8M |